Download presentation- Why transparency between stakeholders is essential when discussing pricing and reimbursement

download, world orphan drug congress, pricing and reimbursement

In November 2012 over 250 delegates participated in the 3rd Annual World Orphan Drug Congress Europe. This event covers strategies and opportunities from Clinical Development and R&D, Market Access, Pricing & Reimbursement , Corporate Development and Drug Repositioning & Indication Expansion. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Ri De Ridder, Director General, National Institute for Health & Disability Insurance.

This presentation covers the following key points:

• A national take on pricing and reimbursement for rare disease treatments
• Economics of treating rare diseases: should orphan drugs even be treated differently when talking price?
• What would be the wider cost of ignoring the rare disease problem?
• While prices are high, how much of healthcare budget is spent of orphan drugs?

Download the full presentation here >

Why not check out our eBook, showcasing the best presentations from the 2012 event. Download a copy here >

The 4th World Orphan Drugs Congress Europe is a content packed, 2 day event with 2 dedicated tracks and is taking place this year in November. For more information about the event, please visit the website >

Leave a Reply

Your email address will not be published. Required fields are marked *